Descriptive study of incidence of side effects of Pegylated interferon alpha therapy and their relation to age, gender, duration of treatment and type of hepatitis in 50 Iraqi patients.
Background: Hepatitis C and B is common disease all over the world and their chronicity is a social and medical problem so medical treatment by alpha interferon can change the mortality and morbidity. Object: Identify the incidence of the side effects of pegylated interferon alpha in a sample of Ir...
Main Author: | Khalid A. AL-Khazraji |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine University of Baghdad
2012-01-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/798 |
Similar Items
-
Research advances in predictors of treatment responses to pegylated interferon alpha in patients with chronic hepatitis B
by: GAO Aihua
Published: (2015-04-01) -
Cutaneous Sarcoidosis: An Uncommon Side Effect of Pegylated Interferon and Ribavirin Use for Chronic Hepatitis C
by: Elson Vidal Martins Jr., et al.
Published: (2009-11-01) -
Individualized treatment with pegylated interferon-α for chronic hepatitis B
by: WAN Mobin
Published: (2018-05-01) -
Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C
by: Jong Wook Choi, et al.
Published: (2016-03-01) -
Antiviral/immunomodulatory combination therapy: Pegylated interferon alpha 2a and ribavirin in patients with chronic hepatitis C virus infection
by: Delić Dragan, et al.
Published: (2012-01-01)